2021-09-30-accounts

RADIOLOGY AND ONCOLOGY CONGRESSES

Registered Number: 04075344 Charity Number: 1087939

ANNUAL REPORT OF THE DIRECTORS and TRUSTEES

AND

FINANCIAL STATEMENTS

FOR THE YEAR ENDED

30 SEPTEMBER 2021

RADIOLOGY AND ONCOLOGY CONGRESSES Annual Report of the Directors and Trustees Year ended 30 September 2021

CONTENTS

Page

i	Annual Report ofthe Directors and Trustees	2-8
1.1	Reference and Administrative Details	2
1.2	Structure, Governance and Management	3
1.3.	Objectives and Activities	4
1.4	Public Benefit	5
1.5	Achievements and Performance	5
1.6	Financial Review	6
1.7	Plans for Future Periods	7
1.8	Acknowledgements	7
1.9	Auditors	7
1.10	Small Company Exemption	7
1.11	Statement ofTrustees’ Responsibilities	7
1.12	Audit Information	8
2.	IndependentAuditors’ Report	9-11
3.	Financial Statements	12 - 20
3.1.	Statement of Financial Activities	12
3.2	Balance Sheets	13
3.3.	Consolidated Cashflow Statement	14
3.4	NotestoFinancialStatements	15-20

1

RADIOLOGY AND ONCOLOGY CONGRESSES Annual Report of the Directors and Trustees Year ended 30 September 2021

1.1 Reference and Administrative Details

Name:	Radiology and Oncology Congresses
	(sometimes abbreviated to ROC)
	Company Registration Number: 04075344.
	Charity Number: 1087939.
Principal Office:	Fairmount House,
	230, Tadcaster Road, York, YO24 1ES
Registered Office:	Fairmount House,
	230, Tadcaster Road, York, YO24 1ES
Auditors:	CLA Evelyn Partners Limited, 45 Gresham Street,
	London, EC2V 7BG
Bankers:	Unity Trust Bank, Four Brindley Place,
	Birmingham, B1 2JB
Solicitors:	Wilsons, Alexandra House, St John’s Street, Salisbury, SP1 2SB
Members ofthe Company:
	The British Institute of Radiology
	The College of Radiographers
	TheInstituteofPhysicsandEngineeringinMedicine

Radiology and Oncology Congresses Board:

Board Members are both Directors of the Company and Trustees of the Charity.

Chairman

Ms P. Black

Hon. Treasurer

Dr C. J. Kotre

Directors Ms C. Donaldson

Mr R.M. Evans

Dr R.A. Malik (appointed 29 June 2021)

Mr P.W. Morgan Prof. S.A.P.O’Connor

Dr S. Redla

Mr I.S. Thomson Dr N.J. B. Spencer, President UKIO 2020 (resigned 6 July 2022)

Honorary Officers:

Marketing Support Mr Richard Evans Exhibition Support Mrs Elizabeth Beckmann

Finance Officer Mr John Turner

2

RADIOLOGY AND ONCOLOGY CONGRESSES Annual Report of the Directors and Trustees Year ended 30 September 2021

1.2 Structure, Governance and Management

1.2.1 Governing Documents

The organisation is a charitable company limited by guarantee, incorporated on the 15 September 2000 and registered as a charity on the 9 August 2001. The company was established under a Memorandum of Association which established the objects and powers of the charitable company and it is governed under its Articles of Association. The current Memorandum and Articles of Association were adopted at the Company’s AGM held on September 9!" 2020.

1.2.2 Recruitment and Appointment of Board

General meetings of the company are either the Annual General Meeting (AGM) or an Extraordinary General Meeting (EGM). The Directors of the company are also Trustees of the charity and are elected by the members at either the AGM or an EGM. One third (or the number nearest one third) of the Directors who are individuals must retire at each AGM, those longest serving retiring first. The individual Directors are either the current President of the congress that the company organises or individuals elected from nominations by members.

There are currently two Honorary Officers of the Board who are Directors and are elected at an AGM or EGM.

1.2.3 Trustee Induction and Training

All Trustees are familiar with the work of the charity and most have served as Trustees of the member organisations or related organisations.

The Trustees are made aware of their obligations, are directed to the Charity Commission website for further guidance and a ROC Handbook is provided. The Board regularly reviews whether any further training is required.

The Board continues to monitor the mix of skills provided by the Trustees and attempts to ensure the Board has a spread of appropriate skills.

1.2.4 Risk Management

The Board regularly reviews the risks to which the charity is exposed and listed below are the six highest identified risks, together with the steps being taken to mitigate those risks.

Relationship with, and commitment of, professional bodies involved in radiology and oncology - SCOR, BIR, IPEM, specialist societies etc. - promoting multi-professional meetings

All Board members are aware of the importance of commitment and good working relationships between ROC, member organisations and other parties, and strive to maintain them. Where conflicts of interest exist they are dealt with transparently. A high emphasis is placed on working in partnership, recognizing the contributions and perspectives of all concerned.

Promotion of multi-disciplinary Congresses and risk of competing events (multi-disciplinary in UK and abroad + specialist society meetings)

The promotion of multi-disciplinary Congresses is one of a number of fundamental Joint Objectives agreed by all ROC’s member organisations. Board members are aware of the need to be aware of potentially competing events which might adversely impact on delegate/exhibitor numbers and keep such matters under strategic review.

Appropriateness and accuracy of content of Congress programmes

All aspects of Congress programmes are reviewed, prospectively and retrospectively, at regular Board meetings. Congress Presidents play a particularly important role in the development of the content of Congress programmes, with oversight by the Board.

Continued attractiveness and relevance of ROC events

Congress Presidents, who are appointed by the Board, are experts in their fields. They are supported by multidisciplinary colleagues with, collectively, a good understanding of the Continuing Professional Development

3

RADIOLOGY AND ONCOLOGY CONGRESSES Annual Report of the Directors and Trustees Year ended 30 September 2021

needs of delegates. All concerned are strongly motivated to ensure the continued attractiveness and relevance of ROC events, in line with ROC’s charitable object.

Complete failure/cancellation of an event

Preparations for events, including associated financial risks, are kept under continual review, augmented by minuted reports at ROC-E board meetings at 3-monthly intervals. We have contracted a professional conference organiser, whose day-to-day business is to ensure the success of events. The charity is further protected by an insurance policy against sudden cancellation of the event for outside circumstances other (unfortunately) than a pandemic.

1.2.5 Organisational Structure

The Board meets at least twice a year and the primary responsibilities of the Board, the two Honorary Officers and the Executive Committee are set out in the Articles of Association. Board effectiveness is reviewed as part of an ongoing process of review of all ROC and ROC-E operations.

The charity does not employ any management staff. Strategy decisions are discussed and approved by the Board of Trustees, and operational delivery is the responsibility of ROC Events Ltd, the wholly-owned subsidiary company, reporting to the Board of Trustees. The Board is supported by a qualified Finance Officer who provides financial and administrative support, who receives a modest payment, and the services of a Professional Conference Organising company. Since April 2020 Company Secretarial responsibilities have been undertaken by one of the members, IPEM, for which it is remunerated. None of the Board members is remunerated.

There is one Committee reporting to the Board: the UKIO Organising Committee. All members of the committee are volunteers. This committee advises the Board as to the scientific programme for the annual UK Imaging and Oncology Congress.

1.3 Objectives and Activities

The object of the Charity shall be to advance education in radiology, oncology and related sciences, particularly by the provision of congresses pertaining to the radiation sciences as applied to medicine, and the dissemination for public benefit of the useful results of reports of research arising from such congresses.

The company brings together three of the main UK professional organisations involved in radiology, medical imaging and radiation oncology to organise an annual major combined event encompassing diagnostic and therapeutic use of imaging and radiation.

The main objective for 2020 - 2021 was to organise the UK Imaging and Oncology Congress (UKIO). The Directors had hoped that UKIO could once again be held as a physical event, but unfortunately due to the uncertainties surrounding the post- Covid reopening and the long lead time necessary for planning such a conference the decision was taken to hold the 2021 event virtually, with a much fuller programme than in 2020.The event ultimately took place virtually during the three weeks June 7‘ -25'" 2021.

Volunteers undertake most of the organising of the scientific planning of the congresses.

4

RADIOLOGY AND ONCOLOGY CONGRESSES Annual Report of the Directors and Trustees Year ended 30 September 2021

1.4 Public Benefit

The Trustees have complied with their duty in section 17 of the Charities Act 2011 to have due regard to the guidance on public benefit published by the Commission in exercising their powers and planning the activities of the charity, including the guidance “Public Benefit: running a charity (PB2)”.

The company has charitable purposes, as set out in 1.3 above, which are for public benefit. They cover three of the descriptions of charitable purpose set out in the Charities Act 2011:

e The advancement of education; e The advancement of health; e The advancement ofthe arts, culture, heritage or science.

The Charity Commission has set out two key principles of public benefit:

There must be an identifiable benefit or benefits

The congress, which the charity organises as its main activity, advances the education and training of a range of persons involved in healthcare through lectures, debates and teaching sessions that not only relate to clinical practice but also include service delivery and standards. It also advances scientific knowledge in medicine and related areas. These two types of activities promote the advancement of education, health and science.

Benefits must be to the public, or section of the public

The main direct beneficiaries of the activities of the charity are healthcare professionals and researchers involved in the areas of medical imaging and treatment of cancer using radiation. The main professions involved include medical doctors, radiographers, medical physicists and industrialists. Underlying the entire operations of Radiology and Oncology Congresses is the belief that its activities are to the benefit of the public, and in particular to patients undergoing diagnostic or therapeutic radiological procedures.

The congress as originally envisaged was open to all, with no preferential registration fees for members of particular societies or organisations. There are wide public benefits from improved healthcare resulting from the activities of the charity.

Radiology and Oncology Congresses does not engage in any political activity.

1.5 Achievements and Performance

Radiology and Oncology Congresses (ROC) is a charitable company, registered with both the Charity Commission and Companies House. It is a private limited company incorporated by guarantee. Its aims and activities are encapsulated in its charitable object — fo advance education in radiology, oncology and related sciences particularly by the provision of congresses pertaining to the radiation sciences as applied to medicine and the dissemination for the public benefit of the useful results of reports of research arising from such congresses. It had been hoped that UKIO 2021 could once again be held as a physical event, but unfortunately due to the uncertainties surrounding the post- Covid reopening and the long lead time necessary for planning such a conference the decision was taken to hold the event virtually, with a much fuller programme than in 2020. Delegate and exhibitor safety is the primary concern of the Board and to hold such an event with anywhere near its normal attendance would obviously have constituted a risk of being a “spreader event” even if it had been legally permissible for it to take place.

The congress took place online June7-25" with the theme “Connect and Transform”. With more time to prepare and plan online delivery that in the prior year a substantially larger programme was delivered.

The number of sessions was 125, delivered by 353 speakers; a total of number of 1,027 live delegates registered on average for 10 sessions each. Unlike the prior year delegates were charged a modest fee for attendance. Engagement has continued on the platform after the congress closed.

Whilst there was no physical presence, many of our usual exhibitors purchased tiered sponsorship packages, with

5

RADIOLOGY AND ONCOLOGY CONGRESSES Annual Report of the Directors and Trustees Year ended 30 September 2021

options to engage with delegates digitally.

Whilst the number of individuals attending was lower than the 4,949 — of whom 2,562 were based outside the UK - who attended the more limited (and free) 2020 virtual conference participation was only marginally below expectations. In common with other regular conferences that have had to operate digitally, we are beginning to see a degree of “digital fatigue”, which combined with pandemic induced pressures on healthcare staff and resulting exhaustion is leading to a short term decline in take-up.

The feedback on the 2021 online congress was positive from a delegate perspective but the sponsors found the opportunities to network with the (virtual) attendees were limited.

The feedback also suggested that there was a strong appetite amongst both exhibitors and delegates for retaining a physical format when this would be safe. The Company was delighted to be able to run the 2022 congress as a faceto-face event in Liverpool in early July which early feedback — both operational and financial — suggests was very successful.

The Directors have for some time recognised that financial and workload pressures affect budgets and ability to attend educational events and been aware of the opportunities and challenges of aspects such as digitisation of educational provision. If there is positive outcome of the COVID pandemic it is the acceleration of the development of ROC-E’s digital offering and increase in accessibility. However, it is apparent is that there is still a strong demand for comprehensive “broad brush” flagship events such as UKIO and the networking opportunities it offers and 2023 will once again take place in Liverpool in June 2023

1.6 Financial Review

1.6.1 Financial Activities

Total income for the year for the charity was £5,100 (2020: £20,472), The prior year included £8,519 distributed by its subsidiary in respect of its profits arising in the financial year ending 30/09/2019. Direct operational and governance costs totalled £42,780 (2020: £58,909). The prior year costs included work on a major upgrade of the Congress website which has been suspended. As a result of the continuing losses incurred by ROC Events Limited it has been judged necessary to provide for an additional impairment of the loan to the entity, a further write down of £24,204 corresponding to the loss for the year of the subsidiary. The aggregate deficit of the charity was £63,204 (2020: £222,197).

Through its subsidiary, ROC Events Ltd, the charity organised the United Kingdom online Imaging and Oncology Congress (UKIO). Although the subsidiary as a whole incurred a loss of £24,204 the Directors note that £51,818 of costs were attributable to historic commitments to hiring the physical venue for a congress which ultimately did not take place and that the virtual congress, on a stand-alone basis, made a small profit. The net loss for the prior year was £193,360.

The Group figures for 2021 reflect the inclusion of the gross income and expenditure for the charity's trading subsidiary, ROC Events Ltd.

No grants were made in the year under report. During the year the Charity funded the cost of publishing the 2021 congress papers. Work is on-going to identify further areas where the charity might better use its scientific meetings to engage with the broader public and encourage the development of young professionals within the sector.

1.6.2 Reserves

The group loss of £62,353 has caused the group reserves to reduce to £339,800 at 30 September 2021 (2020: £402,153). The Trustees have reviewed the Reserves Policy and believe it appropriate to require a minimum of £250,000 to provide working capital for the Group, as suitable venues need to be booked significantly in advance to ensure stability for the events organised by the charity. The Trustees will review the strategic requirements of the scientific meetings in the coming years to build on the current outreach elements of the meetings and consider that the balance of free reserves which will still be available provides a firm financial base for these developments.

6

RADIOLOGY AND ONCOLOGY CONGRESSES Annual Report of the Directors and Trustees Year ended 30 September 2021

1.7 Plans for Future Periods

Whilst the “enforced” reduced and virtual 2021 congress was a success there remains considerable appetite from delegates and exhibitors for physical congress — provided of course that it can be held safely. As referred to above the Company held the 2022 UK Imaging and Oncology (UKIO) in Liverpool in early July 2022 and will return to Liverpool in June next year for the 2023 congress.

1.8 Acknowledgements

The Board of Trustees wishes to pay special tribute to the enormous hard work by the congress's President and Committee, on whom the success of the congresses is entirely dependent. The Board also wishes to acknowledge the excellent contribution of the professional conference organiser, Profile Productions Ltd, towards the effective and professional staging of the 2021 event. That an entire and varied conference programme was successfully delivered online and under difficult circumstances demonstrates their level of commitment and professionalism

1.9 Auditors

CLA Evelyn Partners (formerly Nexia Smith & Williamson), first appointed for the audit of the financial statements for the period ending September 30th 2019, is the auditor.

1.10 Small Company Exemption

The report and the financial statements have been prepared in accordance with the provisions of the Companies Act 2006 relating to small companies.

1.11 Statement of Trustees’ Responsibilities

The Trustees (who are also directors of the Radiology and Oncology Congresses for the purposes of company law) are responsible for preparing the Trustees’ Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires Trustees to prepare financial statements for each financial year which give a true and fair view of the state of the affairs of the charitable company and the group and of the income and expenditure of the charitable group for that period. In preparing these financial statements, the Trustees are required to:

• e select suitable accounting policies and then apply them consistently;

• e observe the methods and principles in the Charities SORP;

• e make judgements and estimates that are reasonable and prudent;

• e state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;

• e prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charitable company will continue in business.

The Trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

7

RADIOLOGY AND ONCOLOGY CONGRESSES Annual Report of the Directors and Trustees Year ended 30 September 2021

1.12 Audit Information

In so far as each of the trustees are aware:

a) there is no relevant information of which the charitable company’s auditor is unaware; and b) the Trustees have taken all relevant steps they ought to have taken to make themselves aware of any relevant audit information and to establish that the charitable company’s auditor is aware of that information.

Signed on behalf of the Trustees by:

ii ital 5

P. Black 26 July 2022

8

RADIOLOGY AND ONCOLOGY CONGRESSES

INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OF RADIOLOGY AND ONCOLOGY CONGRESSES

Opinion

We have audited the financial statements of Radiology and Oncology Congresses (the ‘parent charitable company’) and its subsidiary (the ‘group’) for the year ended 30 September 2021 which comprise Consolidated and Company Statement of Financial Activities, the Group and Company Balance Sheets, the Consolidated Cash Flow Statement and the notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (United Kingdom Generally Accepted Accounting Practice).

In our opinion, the financial statements:

• e give a true and fair view of the state of the group’s and of the parent charitable company’s affairs as at 30 September 2021 and of the group’s income and expenditure for the year then ended;

• e have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and e have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the group and parent charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK; including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group and parent charitable company’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the Annual report of the Directors and Trustees and Financial Statements, other than the financial statements and our auditor’s report thereon. The trustees are responsible for the other information contained within the Annual report of the Directors and Trustees and Financial Statements. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

9

and procedures in relation to compliance with relevant laws and regulations. We also drew on our existing understanding of the charity regulation.

We understand that the group complies with the framework through

• e updating operating procedures and internal controls as legal and regulatory requirements change; and e The Trustees' close oversight through regular board meetings.

In the context of the audit, we considered those laws and regulations which determine the form and content of the financial statements, which are central to the Group’s ability to conduct operations and where failure to comply could result in material penalties. We have identified the following laws and regulations as being of significance in the context of the group:

• © FRS 102 and the requirements of the Companies Act 2006 and the Charities Act 2011 in respect of the preparation and presentation of the financial statements

• e Health and Safety regulations, including building and fire safety; and e Charity law and regulation

We performed the following specific procedures to gain evidence about compliance with the significant laws and regulations above:

• e Making enquiries with management as to the risks of non-compliance and any instances thereof; and e Reading minutes of meetings of those charged with governance.

The senior statutory auditor led a discussion with members of the engagement team regarding the susceptibility of the group’s financial statements to material misstatement, including how fraud might occur. The key areas identified as part of the discussion were management override of controls and revenue recognition, including the manipulation of revenue through fraudulent journal entries.

The procedures carried out to gain evidence in the above areas included:

• e Testing of a sample of manual journal entries, selected through applying specific risk assessments applied based on the Group’s processes and controls surrounding manual journal entries; and

• e Substantive work on revenue transactions.

The senior statutory auditor was satisfied that the engagement team collectively had the appropriate competence and capabilities to identify or recognise irregularities. In particular, both the senior statutory auditor and the audit manager have a number of years’ experience in dealing with group’/s with similar risk profiles.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

Use of our report

This report is made solely to the parent charitable company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the parent charitable company’s members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the parent charitable company, and the parent charitable company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

cL. Evelyn Port voy §

Andrew Bond

Senior Statutory Auditor, for and on behalf of CLA Evelyn Partners Limited Statutory Auditor Chartered Accountants

45 Gresham Street London EC2V 7BG Date ra 4 (7 jz Zu

11

RADIOLOGY AND ONCOLOGY CONGRESSES

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

• e the information given in the Trustees’ Annual Report, which includes the Directors’ Report prepared for the purposes of company law, for the financial year for which the financial statements are prepared is consistent with the financial statements; and

• e the Directors’ Report included within the Trustees’ Annual Report has been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the group and the parent charitable company and their environment obtained in the course of the audit, we have not identified material misstatements in the Directors’ Report included within the Trustees’ Annual Report.

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

• © adequate and sufficient accounting records have not been kept by the parent charitable company, or returns adequate for our audit have not been received from branches not visited by us; or

• e the parent charitable company financial statements are not in agreement with the accounting records and returns; or

• e certain disclosures of trustees’ remuneration specified by law are not made; or

• e we have not received all the information and explanations we require for our audit; or

• e the trustees were not entitled to take advantage of the small companies’ exemption from the requirement to prepare a strategic report.

Responsibilities of trustees

As explained more fully in the Statement of Trustees’ Responsibilities set out on page 8, the trustees (who are directors of the parent charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the trustees are responsible for assessing the group’s and the parent charitable company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the group or the parent charitable company or to cease operations, or have no realistic alternative but to do so.

Auditor’s responsibilities for the audit of the financial statements

We have been appointed as auditor under the Companies Act 2006 and under section 151 of the Charities Act 2011, and report in accordance with those Acts and relevant regulations made or having effect thereunder.

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below:

We obtained a general understanding of the group’s legal and regulatory framework through enquiry of management in respect of their understanding of the relevant laws and regulations. We obtained an understanding of the group’s policies

10

RADIOLOGY AND ONCOLOGY CONGRESSES Financial Statements Year ended 30 September 2021

Consolidated and Company Statement of Financial Activities (Incorporating an Income and Expenditure Account) For the year ended 30 September 2021

		Company	Company	Group	Group
		2021	2020	2021	2020
		£	£	£	£
	Note
INCOME
Income from
Donations from third parties		-	19	-	19
Donation from subsidiary		-	8,519	-	-
Investment income from subsidiary		3,288	7,693	-	-
Interest income from banks		1,812	4,241	1,812	4,241
		5,100	20,472	1,812	4,260
Income from Charitable Activities
UKIO		-	-	237,469	50,000
Total Income		5,100	20,472	239,281	54,260
EXPENDITURE
Charitable activities
Publication of Conference papers		1,320	1,320	1,320	1,320
UKIO	4,5	42,780	58,909	300,314	284,509
Impairment loss on Loan to Subsidiary	10	24,204	182,440	-	-
Total Expenditure		68,304	242,669	301,634	285,829
Deficit foryear		(63,204)	(222,197)	(62,353)	(231,569)
Fund balance brought forward		403,006	625,203	402,153	633,722
Unrestricted funds Balance carried
forward at 30 September 2019		339,802	403,006	339,800	402,153
Company Registration
Number04075344

The notes on pages 15 to 20 form part of these financial statements.

12

RADIOLOGY AND ONCOLOGY CONGRESSES Financial Statements Year ended 30 September 2021

Balance Sheets As at 30 September 2021

		Company	Company	Group	Group
	Notes	2021	2020	2021	2020
Fixed Assets
Investment	8	2	2	-	-
Current Assets
Debtors	10	111,436	42,353	86,742	146,391
Cash at bank and in hand		238,773	370,723	303,319	424 509
		350,211	413,078	390,061	570,900
Creditors: Amounts falling
due within one year	11	10,409	10,072	50,261	168,747
Net Assets
		339,802	403,006	339,800	402,153
Reserves
Unrestricted funds
CarriedForward		339,802	403,006	339,800	402,153

Small Company Exemption

The financial statements have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies and in accordance with the Financial Reporting Standard 102.

The financial statements were approved by the Directors and authorised for issue on 26 July 2022, and signed on its behalf by:

P. Black

Chairman of the Board

C. J. Kotre Honorary Treasurer

Company Registration Number 04075344

The notes on pages 15 to 20 form part of these financial statements.

13

RADIOLOGY AND ONCOLOGY CONGRESSES Financial Statements Year ended 30 September 2021

Consolidated Cashflow Statement For the year ended 30 September 2020

----- Start of picture text -----
|||||||||||||| |---|---|---|---|---|---|---|---|---|---|---|---|---| |2021|2020| |£|£| |Net|cash|(used|in)|/|provided|by|operating|activities|(121,190)|(309,684)| |Change|in|cash|and|cash|equivalents|in|the|reporting|period|(121,190)|(309,684)| |Cash|and|cash|equivalents|at|the|beginning|of|the|reporting|period|424,509|734,193| |Cash|and|cash|equivalents|at|the|end|of the|reporting|period|303,319|424,509|

----- End of picture text -----

Reconciliation of net expenditure to net cash flow from operating activities

----- Start of picture text -----
|||||||||||| |---|---|---|---|---|---|---|---|---|---|---| |2021|2020| |£|£| |Net|expenditure|for the|reporting|period|(62,353)|(231,569)| |Decrease|/|(increase)|in|debtors|59,649|(58,405)| |(Decrease)|/|increase|in|creditors|(118,486)|(19,710)| |Net|cash|(used|in)|/|provided|by|operating|activities|(121,190)|(309,684)| |Analysis|of|cash|and|cash|equivalents| |Cash|in|hand|303,319|424,153| |Total|cash|and|cash|equivalents|303,319|424,153|

----- End of picture text -----

14

RADIOLOGY AND ONCOLOGY CONGRESSES Notes to the Financial Statements For the Year Ended 30 September 2021

• 1 Accounting Policies

• a) Company information

Radiology and Oncology Congresses is a company limited by guarantee domiciled and incorporated in England and Wales. The registered office is Fairmount House, 230, Tadcaster Road, York YO24 1ES.

• b) Accounting Convention

The accounts have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2015) (“Charities SORP (FRS 102)”), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Charities Act 2011.

Radiology and Oncology Congresses, and the group which it heads, meets the definition of a public benefit entity under FRS 102.

The financial statements have been prepared on the historical cost convention. The principal accounting policies adopted are set out below.

Cc) Going Concern The Trustees have a reasonable expectation that the Charity has adequate resources to continue in existence for the foreseeable future. They continue to believe the going concern basis of accounting is appropriate in preparing the financial statements.

The Group rana full congress in July 4th-6th 2022 in Liverpool. Given the lingering impact of COVID 19 on the availability of NHS staff, physical attendance exceeded management's expectations. Our preliminary estimate of the net result of the operating subsidiary for the financial year ending September 30th, 2022, is for a profit in the range £50 K - £100 K and a net cashflow in the range £80 K to £130 K which will enable the operational subsidiary to repay a significant portion of the loan from the Company. Looking further ahead and building on the success of the 2022 Congress we anticipate running the 2023 event, in the same venue and in the same format.

In the light of the success and financial profitability of the 2022 congress and the plans for the 2023 congress, the Directors are of the opinion that Company will be able to continue as a going concern for at least the twelve months following the approval of these accounts.

d) Consolidation The group financial statements consolidate the financial statements of the company and its wholly owned subsidiary undertaking, ROC Events Ltd.

• e) Income

Activities in furtherance of the charity's objectives

Events income is accounted for in the period in which the event takes place.

Investment income

Investment income is account for on an accruals basis.

f) Fund accounting General funds are available for use at the discretion of the Directors in furtherance of the objectives of the charity.

15

RADIOLOGY AND ONCOLOGY CONGRESSES Notes to the Financial Statements For the Year Ended 30 September 2021 (Continued)

g) Expenditure All expenses are accounted for on an accruals basis. Expenditure incurred in connection with the specific objects of the charity is included under the heading charitable expenditure.

Expenditure is classified by the category of activity for which it is used rather than by type of expense. Allocation is on an actual basis, or where this is not possible, on an estimated usage basis.

• e Charitable activities expenditure include both the direct costs and support costs relating to those activities.

• e Governance costs include those incurred in the governance and strategic management of the organisation including costs associated with meeting constitutional and statutory requirements.

• e Support costs, including Governance costs, are allocated to cost categories based on direct costs in those categories.

Liabilities are recognised as soon as there is a legal or constructive obligation committing the charity to the expenditure.

• h) Cash and Cash equivalents Cash and cash equivalents include cash in hand and at bank, and deposits held at call with banks.

• i) Financial Instruments The Group has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the group’s statement of financial position when the company becomes party to the contractual provisions of the instrument.

Basic financial assets, which include trade and other debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Basic financial liabilities, including trade and other creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

• J) Group Accounts

Radiology and Oncology Congresses owns the whole of the share capital of ROC Events Limited. The Directors have elected to prepare consolidated accounts. The whole of any profit of ROC Events Limited, which would otherwise be subject to corporation tax, is donated each year to Radiology and Oncology Congresses.

16

RADIOLOGY AND ONCOLOGY CONGRESSES Notes to the Financial Statements For the Year Ended 30 September 2021 (Continued)

2 Critical Accounting Estimates and Judgements

In the application of the Charity’s accounting policies, the Trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised, if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.

There are no estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities.

3 Members’ Guarantee

Radiology and Oncology Congresses is a company limited by guarantee in England and Wales and has a licence to dispose of the word “limited” in its title. The members are: The British Institute of Radiology, The College of Radiographers, and the Institute of Physics and Engineering in Medicine. In the event of a winding up, the liability of the three members would not exceed £1 each.

4 Analysis of Charitable Expenditure

			2021
	£	£	£	£
	Direct	Admin	Governance	Total
Publishing current year’s conference papers	1,320	-	-	1,320
UKIO 2020 (note 5)	247,822	9,712	42,780	300,314
	249,142	9,712	42,780	301,634
			2020
	5	£	£	£
	Direct	Admin	Governance	Total
Publishing prior year’s conference papers	1,320	-	-	1,320
UKIO 2020 (note 5)	217,536	8,604	58,909	284,509
	218,856	8,604	58,909	285,829

5 Expenditure by the Group

United Kingdom Imaging and Oncology Congress

		2021	2020
		£	£
Direct	Venue Costs	51,817	66,396
Other	Event Costs	196,005	151,140
Total	UKIOCosts	247822	217,536

The direct venue costs for the year related to the partial payment of contractual commitments, the balance of the commitments having been waived by the venue provider.

Ly

RADIOLOGY AND ONCOLOGY CONGRESSES Notes to the Financial Statements For the Year Ended 30 September 2021 (Continued)

----- Start of picture text -----
||||||||| |---|---|---|---|---|---|---|---| |6|Deficit|on|Ordinary|Activities|-|Group| |The|deficit|is|stated|after|charging:|2021|2020| |£|£| |Auditors'|remuneration:|Audit|(excluding|VAT)|12,000|9,414| |Non-Audit|(excluding|VAT)|1,000|900| |Directors’|and|Officers’|Insurance|2,138|1,889|

----- End of picture text -----

7 Trustees' Remuneration

No Trustee received any remuneration during the current or previous year. Travel expenses of £967 (2020: £2,510) were reimbursed to 2 (2020: 2) trustees. The Trustees are considered to be the charity's key management personnel.

8 Fixed Asset Investments

Group investment — company

ROC Events Limited is a wholly owned subsidiary by way of a gift of shares. The company’s registered address is Fairmount House, 230 Tadcaster Road, York, YO24 1ES, its Company number 06722032: it carries out trading activities and its profits are donated to the parent company.

The company has authorised share capital of 100 shares at £1 of which currently only 2 have been issued.

----- Start of picture text -----
||||| |---|---|---|---| |Company|/|Charity| |2021|2020| |Total|investment|£2|£2|

----- End of picture text -----

The following information has been extracted from the financial statements of ROC Events Limited for the year ended 30 September 2021:

----- Start of picture text -----
|||||| |---|---|---|---|---| |2021|2020| |£|£| |Aggregate|Assets|151,289|200,176| |Aggregate|Liabilities|(357,933)|(382,616)| |Reserves|,|(206,644)|(182,440)| |Total|Income|237,469|50,000| |Total|Expenditure|(261,673)|(243,360)| |(Loss)/|Profit|for year|(24,204)|(193,360)|

----- End of picture text -----

18

RADIOLOGY AND ONCOLOGY CONGRESSES Notes to the Financial Statements

For the Year Ended 30 September 2021 (Continued)

10	Debtors	Company/	Charity	Group
		2021	2020	2021	2020
		£	£	£	£
	Trade debtors	-	-	11,152	5,365
	Amounts owed by group undertakings	318,080	224,793	-	-
	Less: Provision for doubtful debts	(206,644)	(182,440)	-	-
	Prepayments	-	-	47,740	99,637
	VAT repayment	-	-	27,850	41,389
		111,436	42,353	86,742	146,391

The carrying value of the loan to the subsidiary undertaking ROC Events Limited has been impaired to reflect the fact that the loss it incurred in the year has resulted in a net deficit of £206,644 for which recovery is currently considered unlikely. The subsidiary company runs the annual UKIO congress, which is a charitable activity, and the loan supports the provision of that activity.

11 Creditors

Creditors	Company / Charity	Company / Charity	Group
	2021	2020	2021	2020
	£	£	£	£
Trade creditors	-	-	29,817	142,003
Deferred Income and Accruals	10,409	10,072	20,444	26,744
	10,409	10,072	50,261	168,747

12 Financial Assets

		Company / Charity	Company / Charity	Group
		2021	2020	2021	2020
		£	£	£	£
Carrying	value of Financial Assets
Financial	assets at amortised cost	111,436	42,353	11,152	5,365
Carrying	value of Financial liabilities
Financial	liabilitiesatamortisedcost	10,409	10,072	50,261	168,747

19

RADIOLOGY AND ONCOLOGY CONGRESSES Notes to the Financial Statements For the Year Ended 30 September 2021 (Continued)

13 Taxation

Radiology and Oncology Congresses has charitable status and is exempt from capital and income taxes on its charitable activities.

14 Committed Expenditure

The group has entered into a series of contracts with ACC Liverpool as the venue for the 2022 event and subsequent to the balance sheet date also for the 2023 event. The outstanding commitment in respect of the 2022 congress outstanding at 30 September 2021 was £4,478 (2020: £233,023). The commitment entered into post year-end for 2023 is £173,694.

15 Related Party Transactions

On June 3 2020 the Company granted to its subsidiary ROC Events Limited a new unsecured loan facility for an amount of £500,000 repayable on demand at an interest cost charged interest at a rate of 1% plus the Bank of England base rate on outstanding balances. The previous loan facility of September 20" 2011 was terminated and the balance transferred to the new facility on June 3 2020. Following the substantial loss incurred by ROC Events Limited in the year the carrying value of the loan has been written down to reflect the impairment.

With effect from April 1s! 2020 the Company Secretarial functions for both the Company and its subsidiary ROC Events Ltd. are subcontracted to one of the organisation's members, the Institute of Physics and Engineering in Medicine, for an annual fee of £10,140. For the year ending September 30" 2020 the sum of £5,070 was paid.

20